EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair

Agnieszka Arthur, Romana A. Panagopoulos, Lachlan Cooper, Danijela Menicanin, Ian H. Parkinson, John D. Codrington, Kate Vandyke, Andrew C W Zannettino, Simon A. Koblar, Natalie A. Sims, Koichi Matsuo, Stan Gronthos

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Previous reports have identified a role for the tyrosine kinase receptor EphB4 and its ligand, ephrinB2, as potential mediators of both bone formation by osteoblasts and bone resorption by osteoclasts. In the present study, we examined the role of EphB4 during bone repair after traumatic injury. We performed femoral fractures with internal fixation in transgenic mice that overexpress EphB4 under the collagen type 1 promoter (Col1-EphB4) and investigated the bone repair process up to 12 weeks postfracture. The data indicated that Col1-EphB4 mice exhibited stiffer and stronger bones after fracture compared with wild-type mice. The fractured bones of Col1-EphB4 transgenic mice displayed significantly greater tissue and bone volume 2 weeks postfracture compared with that of wild-type mice. These findings correlated with increased chondrogenesis and mineral formation within the callus site at 2 weeks postfracture, as demonstrated by increased safranin O and von Kossa staining, respectively. Interestingly, Col1-EphB4 mice were found to possess significantly greater numbers of clonogenic mesenchymal stromal progenitor cells (CFU-F), with an increased capacity to form mineralized nodules in vitro under osteogenic conditions, when compared with those of the wild-type control mice. Furthermore, Col1-EphB4 mice had significantly lower numbers of TRAP-positive multinucleated osteoclasts within the callus site. Taken together, these observations suggest that EphB4 promotes endochondral ossification while inhibiting osteoclast development during callus formation and may represent a novel drug target for the repair of fractured bones.

Original languageEnglish
Pages (from-to)926-935
Number of pages10
JournalJournal of Bone and Mineral Research
Volume28
Issue number4
DOIs
Publication statusPublished - 2013 Apr

Fingerprint

Bone Fractures
Osteogenesis
Bone and Bones
Bony Callus
Osteoclasts
Mesenchymal Stromal Cells
Transgenic Mice
Chondrogenesis
Femoral Fractures
Receptor Protein-Tyrosine Kinases
Bone Resorption
Collagen Type I
Osteoblasts
Minerals
Staining and Labeling
Ligands
Wounds and Injuries
Pharmaceutical Preparations

Keywords

  • bone repair
  • endochondral ossification
  • EPHB4
  • mesenchymal stem cells
  • osteoblasts

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Arthur, A., Panagopoulos, R. A., Cooper, L., Menicanin, D., Parkinson, I. H., Codrington, J. D., ... Gronthos, S. (2013). EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair. Journal of Bone and Mineral Research, 28(4), 926-935. https://doi.org/10.1002/jbmr.1821

EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair. / Arthur, Agnieszka; Panagopoulos, Romana A.; Cooper, Lachlan; Menicanin, Danijela; Parkinson, Ian H.; Codrington, John D.; Vandyke, Kate; Zannettino, Andrew C W; Koblar, Simon A.; Sims, Natalie A.; Matsuo, Koichi; Gronthos, Stan.

In: Journal of Bone and Mineral Research, Vol. 28, No. 4, 04.2013, p. 926-935.

Research output: Contribution to journalArticle

Arthur, A, Panagopoulos, RA, Cooper, L, Menicanin, D, Parkinson, IH, Codrington, JD, Vandyke, K, Zannettino, ACW, Koblar, SA, Sims, NA, Matsuo, K & Gronthos, S 2013, 'EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair', Journal of Bone and Mineral Research, vol. 28, no. 4, pp. 926-935. https://doi.org/10.1002/jbmr.1821
Arthur, Agnieszka ; Panagopoulos, Romana A. ; Cooper, Lachlan ; Menicanin, Danijela ; Parkinson, Ian H. ; Codrington, John D. ; Vandyke, Kate ; Zannettino, Andrew C W ; Koblar, Simon A. ; Sims, Natalie A. ; Matsuo, Koichi ; Gronthos, Stan. / EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair. In: Journal of Bone and Mineral Research. 2013 ; Vol. 28, No. 4. pp. 926-935.
@article{4e2df180c61840e2accf2a7c11d8da02,
title = "EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair",
abstract = "Previous reports have identified a role for the tyrosine kinase receptor EphB4 and its ligand, ephrinB2, as potential mediators of both bone formation by osteoblasts and bone resorption by osteoclasts. In the present study, we examined the role of EphB4 during bone repair after traumatic injury. We performed femoral fractures with internal fixation in transgenic mice that overexpress EphB4 under the collagen type 1 promoter (Col1-EphB4) and investigated the bone repair process up to 12 weeks postfracture. The data indicated that Col1-EphB4 mice exhibited stiffer and stronger bones after fracture compared with wild-type mice. The fractured bones of Col1-EphB4 transgenic mice displayed significantly greater tissue and bone volume 2 weeks postfracture compared with that of wild-type mice. These findings correlated with increased chondrogenesis and mineral formation within the callus site at 2 weeks postfracture, as demonstrated by increased safranin O and von Kossa staining, respectively. Interestingly, Col1-EphB4 mice were found to possess significantly greater numbers of clonogenic mesenchymal stromal progenitor cells (CFU-F), with an increased capacity to form mineralized nodules in vitro under osteogenic conditions, when compared with those of the wild-type control mice. Furthermore, Col1-EphB4 mice had significantly lower numbers of TRAP-positive multinucleated osteoclasts within the callus site. Taken together, these observations suggest that EphB4 promotes endochondral ossification while inhibiting osteoclast development during callus formation and may represent a novel drug target for the repair of fractured bones.",
keywords = "bone repair, endochondral ossification, EPHB4, mesenchymal stem cells, osteoblasts",
author = "Agnieszka Arthur and Panagopoulos, {Romana A.} and Lachlan Cooper and Danijela Menicanin and Parkinson, {Ian H.} and Codrington, {John D.} and Kate Vandyke and Zannettino, {Andrew C W} and Koblar, {Simon A.} and Sims, {Natalie A.} and Koichi Matsuo and Stan Gronthos",
year = "2013",
month = "4",
doi = "10.1002/jbmr.1821",
language = "English",
volume = "28",
pages = "926--935",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair

AU - Arthur, Agnieszka

AU - Panagopoulos, Romana A.

AU - Cooper, Lachlan

AU - Menicanin, Danijela

AU - Parkinson, Ian H.

AU - Codrington, John D.

AU - Vandyke, Kate

AU - Zannettino, Andrew C W

AU - Koblar, Simon A.

AU - Sims, Natalie A.

AU - Matsuo, Koichi

AU - Gronthos, Stan

PY - 2013/4

Y1 - 2013/4

N2 - Previous reports have identified a role for the tyrosine kinase receptor EphB4 and its ligand, ephrinB2, as potential mediators of both bone formation by osteoblasts and bone resorption by osteoclasts. In the present study, we examined the role of EphB4 during bone repair after traumatic injury. We performed femoral fractures with internal fixation in transgenic mice that overexpress EphB4 under the collagen type 1 promoter (Col1-EphB4) and investigated the bone repair process up to 12 weeks postfracture. The data indicated that Col1-EphB4 mice exhibited stiffer and stronger bones after fracture compared with wild-type mice. The fractured bones of Col1-EphB4 transgenic mice displayed significantly greater tissue and bone volume 2 weeks postfracture compared with that of wild-type mice. These findings correlated with increased chondrogenesis and mineral formation within the callus site at 2 weeks postfracture, as demonstrated by increased safranin O and von Kossa staining, respectively. Interestingly, Col1-EphB4 mice were found to possess significantly greater numbers of clonogenic mesenchymal stromal progenitor cells (CFU-F), with an increased capacity to form mineralized nodules in vitro under osteogenic conditions, when compared with those of the wild-type control mice. Furthermore, Col1-EphB4 mice had significantly lower numbers of TRAP-positive multinucleated osteoclasts within the callus site. Taken together, these observations suggest that EphB4 promotes endochondral ossification while inhibiting osteoclast development during callus formation and may represent a novel drug target for the repair of fractured bones.

AB - Previous reports have identified a role for the tyrosine kinase receptor EphB4 and its ligand, ephrinB2, as potential mediators of both bone formation by osteoblasts and bone resorption by osteoclasts. In the present study, we examined the role of EphB4 during bone repair after traumatic injury. We performed femoral fractures with internal fixation in transgenic mice that overexpress EphB4 under the collagen type 1 promoter (Col1-EphB4) and investigated the bone repair process up to 12 weeks postfracture. The data indicated that Col1-EphB4 mice exhibited stiffer and stronger bones after fracture compared with wild-type mice. The fractured bones of Col1-EphB4 transgenic mice displayed significantly greater tissue and bone volume 2 weeks postfracture compared with that of wild-type mice. These findings correlated with increased chondrogenesis and mineral formation within the callus site at 2 weeks postfracture, as demonstrated by increased safranin O and von Kossa staining, respectively. Interestingly, Col1-EphB4 mice were found to possess significantly greater numbers of clonogenic mesenchymal stromal progenitor cells (CFU-F), with an increased capacity to form mineralized nodules in vitro under osteogenic conditions, when compared with those of the wild-type control mice. Furthermore, Col1-EphB4 mice had significantly lower numbers of TRAP-positive multinucleated osteoclasts within the callus site. Taken together, these observations suggest that EphB4 promotes endochondral ossification while inhibiting osteoclast development during callus formation and may represent a novel drug target for the repair of fractured bones.

KW - bone repair

KW - endochondral ossification

KW - EPHB4

KW - mesenchymal stem cells

KW - osteoblasts

UR - http://www.scopus.com/inward/record.url?scp=84875324671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875324671&partnerID=8YFLogxK

U2 - 10.1002/jbmr.1821

DO - 10.1002/jbmr.1821

M3 - Article

C2 - 23165754

AN - SCOPUS:84875324671

VL - 28

SP - 926

EP - 935

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 4

ER -